Literature DB >> 849146

Limb-preserving vascular surgery for malignant tumors of the lower extremity.

J G Fortner, D K Kim, M H Shiu.   

Abstract

Monobloc soft-part resections have been carried out with excision of segments of the illac and femoral vessels in seven patients with cancer in the lower extremity. Amputation would have been necessary otherwise. Ischemic loss of the extremity did not occur. In four of the earlier patients, vascular reconstruction was not performed, and postoperative lymphedema was a major complication. In the recently treated three patients, complete reconstitution of the circulation by simultaneous arterial and venous grafting permitted smooth postoperative recovery and absence of notable edema. Creation of a distal arteriovenous fistula appears essential to maintain venous patency. Six of the seven patients are alive at six months, 1, 3, 4, 7, and 18 years, respectively. One patient died of pulmonary metastases at three years after operation. Two patients developed local recurrences requiring limb disarticulation, both in the earlier group in which excision and grafting of both artery and vein was not done. It is concluded that excision and simultaneous reconstruction of major blood vessels can extend the scope of soft-part resections for cancer of the extremities, offering opportunities for preservation of limbs that would otherwise require amputation for control of disease.

Entities:  

Mesh:

Year:  1977        PMID: 849146     DOI: 10.1001/archsurg.1977.01370040043007

Source DB:  PubMed          Journal:  Arch Surg        ISSN: 0004-0010


  9 in total

1.  Management of great vessels and nerves in limb-salvage surgery for bone and soft tissue tumors.

Authors:  Deng-xing Lun; Yong-cheng Hu; Hong-chao Huang
Journal:  Orthop Surg       Date:  2013-11       Impact factor: 2.071

Review 2.  Resection and reconstruction of pelvic and extremity soft tissue sarcomas with major vascular involvement: Current concepts.

Authors:  Niall P McGoldrick; Joseph S Butler; Maire Lavelle; Stephen Sheehan; Sean Dudeney; Gary C O'Toole
Journal:  World J Orthop       Date:  2016-05-18

3.  Vascular management in rotationplasty.

Authors:  Craig R Mahoney; Curtis W Hartman; Pamela J Simon; B Timothy Baxter; James R Neff
Journal:  Clin Orthop Relat Res       Date:  2008-03-18       Impact factor: 4.176

4.  Long-term outcome after multivisceral and tumor/vascular resection in patients with soft tissue sarcoma.

Authors:  P Vogel; U Bolder; M N Scherer; H-J Schlitt; K-W Jauch
Journal:  Langenbecks Arch Surg       Date:  2008-08-12       Impact factor: 3.445

5.  Outcomes after Arterial or Venous Reconstructions in Limb Salvage Surgery for Extremity Soft Tissue Sarcoma.

Authors:  Daedo Park; Sungsin Cho; Ahram Han; Chanjoong Choi; Sanghyun Ahn; Sang-Il Min; Jongwon Ha; Seung-Kee Min
Journal:  J Korean Med Sci       Date:  2018-09-13       Impact factor: 2.153

6.  Outcomes of Vascular Resection and Reconstruction in Extremity Soft Tissue Sarcoma and Bone Tumors.

Authors:  AnChetan Shah; Vishnu Ramanujan; Krishna Muralidharan; Anand AnRaja
Journal:  Vasc Specialist Int       Date:  2021-03-31

7.  Reconstruction of the superficial femoral vessels with muscle flap coverage for soft tissue sarcomas of the proximal thigh.

Authors:  Pauliina Homsy; Ilkka Kantonen; Juho Salo; Anders Albäck; Erkki Tukiainen
Journal:  Microsurgery       Date:  2022-06-22       Impact factor: 2.080

8.  Limb conservation in extremity soft tissue sarcomas with vascular involvement.

Authors:  Rajaraman Ramamurthy; Jagadish Chandra Bose Soundrarajan; Viswanathan Mettupalayam; Subbiah Shanmugham; Balasubramanian Arumugam; Saravanan Periasamy
Journal:  Indian J Orthop       Date:  2009-10       Impact factor: 1.251

9.  The Orthopedic-Vascular Multidisciplinary Approach Improves Patient Safety in Surgery for Musculoskeletal Tumors: A Large-Volume Center Experience.

Authors:  Andrea Angelini; Michele Piazza; Elisa Pagliarini; Giulia Trovarelli; Andrea Spertino; Pietro Ruggieri
Journal:  J Pers Med       Date:  2021-05-24
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.